Pharmachronicles

Top Menu

  • Home
  • Our Blog
  • Contact Us

Main Menu

  • Home Page
  • STUDENTS ZONE
  • Syllabus
  • Seminars & conferences
  • Online classes
    • Register
Sign in / Join

Login

Welcome! Login in to your account
Lost your password?

Lost Password

Back to login
  • Home
  • Our Blog
  • Contact Us

Pharmachronicles

Header Banner

Pharmachronicles

  • Home Page
  • STUDENTS ZONE
  • Syllabus
  • Seminars & conferences
  • Online classes
    • Register
  • UGC-Cancelled-List of journals

  • NAAC stops accepting applications for accreditation from pharmacy colleges

  • Pursuing MPhil/PhD while working as a teacher will effect experience: UGC

  • Public notice by government of india ministry of health and family welfare

Medical & Health
Home›Medical & Health›A trial finds new revolution in migraine treatment

A trial finds new revolution in migraine treatment

By Ramoju kishore kumar
June 20, 2018
585
0
Share:

A new treatment for preventing migraines in patients with frequent attacks, and it has shown a good effect withoutany side effects.

In American Academy of Neurology annual meeting, a data regarding the phase 3 trial has presented. it was stated as a monthly injection of the drug Erenumab have decreased the number of migraines experienced by patients with an episodic migraine.

Erenumab is a human monoclonal antibody designed to target a receptor for calcitonin gene-related peptide (CGRP), a protein involved in the transmission of pain signals and dilation of blood vessels that have been implicated to play a major role in migraines.

In current condition, most of the doctors are prescribing triptans in order to relive the migraine condition exact mechanism of the drug was not known yet mainly like how this drug stops the migraine attack. We now have evidence that triptans inhibit release of CGRP from overactive nerves in the trigeminal ganglion – a collection of nerve fibers that innervate the head, eye, and jaw. Unfortunately, taking a pill after you have a migraine is only a band-aid treatment, and people who get episodic or chronic migraines (15 or more episodes a month) are typically recommended to try one of several preventative medications. These prophylactic agents must be taken every day and have mixed success. Furthermore, they may cause side effects as debilitating as the migraines themselves.

Erenumab, on the other hand, directly blocks migraine development by binding to the CGRP receptors on nerve cells, thus preventing CGRP from binding.

In a not-yet-published trial run by pharmaceutical company Novartis, 246 episodic migraine sufferers who had already tried two to four prophylactic medications to no avail were given injections of erenumab or a placebo once a month for three months. During the treatment period, 30 percent of the people who received erenumab experienced half the number of migraines that they had previously, compared with only 14 percent of placebo patients.

Patients taking erenumab reported mild side effects that were similar to those on the placebo. But as per the novartis’ collaborator Amgen, A trial involving more than 3,000 patients have demonstrated the drug is safe and effective for up to five years.

One of the neuroscientists has expressed his views regarding the Erenumab treatment for a migraine as “This is the first-ever mechanism specific migraine drug designed for prevention, This will change migraine treatment for those who don’t respond to conventional treatments.”

Dr Mark Toms, a chief scientific officer at Novartis UK, said: “There has been no real advancement in migraine treatment for the past 20 years and we’re proud to be breaking new ground in neurology for the millions of people in the UK living with the painful and disruptive symptoms of migraine.

TagsAmgenMigraineNovarits
Previous Article

EEG Machine to Create Digital Images From ...

Next Article

Clinical trial of the HIV vaccine proves ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0
Avatar photo

Ramoju kishore kumar

Related articles More from author

  • Medical & Health

    Mens with migraine headache has an elevated levels of female sex hormone.

    July 9, 2018
    By Ramoju kishore kumar
  • Medical & Health

    Good Sleep, cheerful Mood can Stay Sharper In Old Age

    February 15, 2020
    By Sriram Nagarajan
  • Medical & Health

    EEG Machine to Create Digital Images From Brain Activity

    April 14, 2018
    By Ramoju kishore kumar
  • Educational newsMedical & HealthMedical research

    First ever 3D printing heart by scientist using human tissue

    April 18, 2019
    By Sriram Nagarajan
  • DiseaseMedical & HealthMedical researchTreatment

    Excess weight and body fat cause cardiovascular disease

    June 18, 2019
    By Ramoju kishore kumar
  • Medical & HealthMedical research

    IMMUNITY

    June 18, 2019
    By Sundari srinidhi

Leave a reply Cancel reply

You may interested

  • Uncategorized

    Combining exercise and dieting may not be a good idea as it may impact our bone health

  • Phama news

    QUALITY IMPROVEMENT PROGRAMME For Teachers of Pharmacy Colleges

  • Syllabus

    JNTUH Hyderabad B.Pharm Syllabus

  • LATEST REVIEWS

  • TOP REVIEWS

  • Pharmacists are not eligible for certificate program of community health

    0
  • A New Class of Antimicrobials Has Just Been Found in Human Breast Milk Fresh super ...

    0

Timeline

  • May 24, 2021

    LIST OF SCOPUS INDEXED JOURNALS APRIL 2021

  • October 20, 2020

    List of UGC Approved journals 2020

  • June 8, 2020

    Brain Tumor Day -8th June – Endoscopic surgery: An innovative approach to treat brain tumour

  • June 4, 2020

    UGC-Cancelled-List of journals

  • June 1, 2020

    Saroj Group Of Hospitals restarts its complete operations – see major footfall in OPD consultation

Latest Comments

  • Sowmya V
    on
    December 13, 2019
    Nice keep it up

    Blood Test Might Predict Pregnancy Due Date and Preterm Birth

Find us on Facebook

Follow Us on Instagram

logo

Dui viverra Faucibus aliquet quis phasellus accumsan. Donec et facilisis sociosqu sed tortor elit eu aliquid turpis ridiculus.

Fly, shall, have greater fifth spirit midst under from stars thing is, had creepeth multiply kind. Man may they’re meat years have third bring replenish air two light deep fill.

About us

  • Dr.N.Sriram, Founder CEO, Pharmachronicles, HITS college of Pharmacy, Ghatkesar, Hyderabad, India
  • 9704361947
  • pharmachronicles@gmail.com
  • Recent

  • Popular

  • Comments

  • LIST OF SCOPUS INDEXED JOURNALS APRIL 2021

    By admin
    May 24, 2021
  • List of UGC Approved journals 2020

    By admin
    October 20, 2020
  • Brain Tumor Day -8th June – Endoscopic surgery: An innovative approach to treat brain tumour

    By Sriram Nagarajan
    June 8, 2020
  • UGC-Cancelled-List of journals

    By admin
    June 4, 2020
  • Blood Test Might Predict Pregnancy Due Date and Preterm Birth

    By Sundari srinidhi
    December 12, 2019
  • FDA is carefully evaluating prescription opioid medications approved to treat cough in children

    By admin
    July 16, 2015
  • Record Numbers of FDA‑Approved Drugs: Recent Trends

    By admin
    July 16, 2015
  • There make for Sixth that multiply blessed two divide creeping

    By admin
    July 16, 2015
  • Sowmya V
    on
    December 13, 2019

    Blood Test Might Predict Pregnancy Due Date and Preterm Birth

    Nice keep it up

Photostream

    Follow us

    • Contact
    • STUDENTS ZONE
    • About Us
    © Copyright Pharmachronicles. All rights reserved.